Eisai Co - Company & Market Research Reports

Eisai Limited is a research-based pharmaceutical company that develops, manufactures, and markets healthcare products for patients and their families. It offers products in the areas of Alzheimer's disease, gastrointestinal disorders, epilepsy, cervical dystonia, severe chronic pain, and oncology. The company was founded in 1988 and is based in Hatfield, United Kingdom. It also has operations in the United States, Asia, and Europe.

Oncology drug report - Votrient - pazopanib - 2009-2015 analysis; 2016-2021 expectations - Product Thumbnail Image

Oncology drug report - Votrient - pazopanib - 2009-2015 analysis; 2016-2021 expectations

  • Report
  • 63 Pages
From
Bladder and Ureter Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Bladder and Ureter Cancer Drug Development Pipeline Review, 2017

  • Report
  • 150 Pages
From
Global Cancer Supportive Care Therapeutics Market to 2022 - Patent Expirations Create Opportunities for Biosimilars in the Chemotherapy Induced Anemia and Neutropenia Markets - Product Thumbnail Image

Global Cancer Supportive Care Therapeutics Market to 2022 - Patent Expirations Create Opportunities for Biosimilars in the Chemotherapy Induced Anemia and Neutropenia Markets

  • Report
  • 126 Pages
From
The World Market for Cancer Therapeutics (Monoclonal Antibodies, TKIs, Vaccines, Cytokines, Gene Therapy, Chemotherapy, Others), Phase I- III Pipeline Analysis, Markets by Segment - Product Thumbnail Image

The World Market for Cancer Therapeutics (Monoclonal Antibodies, TKIs, Vaccines, Cytokines, Gene Therapy, Chemotherapy, Others), Phase I- III Pipeline Analysis, Markets by Segment

  • Report
  • 320 Pages
From
Thyroid Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Thyroid Cancer - Pipeline Review, H1 2018

  • Report
  • 567 Pages
From
Thyroid Cancer - Pipeline Insight, 2018 - Product Thumbnail Image

Thyroid Cancer - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Anaplastic Thyroid Cancer - Pipeline Insight, 2018 - Product Thumbnail Image

Anaplastic Thyroid Cancer - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
2018 hepatitis C Drug Development- Pipeline Analysis Report - Product Thumbnail Image

2018 hepatitis C Drug Development- Pipeline Analysis Report

  • Report
  • 200 Pages
From
Global Gout Therapeutics Market 2016-2020 - Product Thumbnail Image

Global Gout Therapeutics Market 2016-2020

  • Report
  • 59 Pages
From
Global Anti-Obesity Drugs Market Trends and Drivers, Restraints, and Opportunities 2017-2023 - Product Thumbnail Image

Global Anti-Obesity Drugs Market Trends and Drivers, Restraints, and Opportunities 2017-2023

  • Report
  • 71 Pages
From
Papillary Thyroid Cancer - Pipeline Review, H2 2015 - Product Thumbnail Image

Papillary Thyroid Cancer - Pipeline Review, H2 2015

  • Report
  • 115 Pages
From
Natural Killer Cell Lymphomas Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Natural Killer Cell Lymphomas Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • 147 Pages
From
2018 Pancreatitis Drug Development- Pipeline Analysis Report - Product Thumbnail Image

2018 Pancreatitis Drug Development- Pipeline Analysis Report

  • Report
  • 50 Pages
From
Oncology Drug Report - Herceptin - Trastuzumab - 2006-2015 Analysis; 2016-2021 Expectations - Product Thumbnail Image

Oncology Drug Report - Herceptin - Trastuzumab - 2006-2015 Analysis; 2016-2021 Expectations

  • Report
  • 58 Pages
From
Oncology Drug Report - Perjeta - Pertuzumab - 2012-2015 Analysis; 2016-2021 Expectations - Product Thumbnail Image

Oncology Drug Report - Perjeta - Pertuzumab - 2012-2015 Analysis; 2016-2021 Expectations

  • Report
  • 53 Pages
From
Obesity Drugs and Therapies: Technologies and Global Markets - Product Thumbnail Image

Obesity Drugs and Therapies: Technologies and Global Markets

  • Report
From
Belviq 2016 U.S Promotional Report - Product Thumbnail Image

Belviq 2016 U.S Promotional Report

  • Report
  • 24 Pages
From
Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030 - Product Thumbnail Image

Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030

  • Report
  • 350 Pages
From
Lenvima 2016 U.S Promotional Report - Product Thumbnail Image

Lenvima 2016 U.S Promotional Report

  • Report
  • 26 Pages
From
Anti-Obesity Drugs - Global Strategic Business Report - Product Thumbnail Image

Anti-Obesity Drugs - Global Strategic Business Report

  • Report
  • 143 Pages
From
Loading Indicator
adroll